Finally, because insulin signals independently of RAS-PI3Kα interaction, drugs that break this interaction are unlikely to induce glucose metabolism disorders (Taha and Klip, 1999; Liu et al, 2006; Simanshu et al, 2025). This evidence concerns the gene INS and glucose metabolism disease.